Clinical significance of histone deacetylase (HDAC)-1, HDAC-2, HDAC-4, and HDAC-6 expression in human malignant and benign thyroid lesions
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical significance of histone deacetylase (HDAC)-1, HDAC-2, HDAC-4, and HDAC-6 expression in human malignant and benign thyroid lesions
Authors
Keywords
Thyroid malignancy, Histone deacetylases, Clinicopathological parameters, Immunohistochemistry
Journal
TUMOR BIOLOGY
Volume 35, Issue 1, Pages 61-71
Publisher
Springer Nature
Online
2013-07-19
DOI
10.1007/s13277-013-1007-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Expression of Class I Histone Deacetylases Indicates Poor Prognosis in Endometrioid Subtypes of Ovarian and Endometrial Carcinomas
- (2015) Wilko Weichert et al. NEOPLASIA
- Eph-A2 and Eph-A4 expression in human benign and malignant thyroid lesions: An immunohistochemical study
- (2013) Nikolaos P. Karidis et al. MEDICAL SCIENCE MONITOR
- The role of cytology specimens in molecular testing of solid tumors: Techniques, limitations, and opportunities
- (2012) Dara L. Aisner et al. DIAGNOSTIC CYTOPATHOLOGY
- Targeting histone deacetylase in thyroid cancer
- (2012) Diego Russo et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Belinostat: clinical applications in solid tumors and lymphoma
- (2011) L Rhoda Molife et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- HDAC inhibitors in cancer biology: emerging mechanisms and clinical applications
- (2011) Omar Khan et al. IMMUNOLOGY AND CELL BIOLOGY
- Epigenetics of thyroid cancer and novel therapeutic targets
- (2011) Diego Russo et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- Histone deacetylase-1 and -2 expression in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients survival
- (2011) Stamatios Theocharis et al. JOURNAL OF ORAL PATHOLOGY & MEDICINE
- Therapy of thyroid carcinoma with the histone deacetylase inhibitor MS-275
- (2010) Annette Altmann et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Increasing incidence of thyroid cancer: is diagnostic scrutiny the sole explanation?
- (2010) Elizabeth M Ward et al. Future Oncology
- Novel histone deacetylase inhibitors in clinical trials as anti-cancer agents
- (2010) Jiahuai Tan et al. Journal of Hematology & Oncology
- Evaluation of FAK and Src Expression in Human Benign and Malignant Thyroid Lesions
- (2010) Christina Michailidi et al. PATHOLOGY & ONCOLOGY RESEARCH
- Modulation of matrix metalloproteinase activity in human thyroid cancer cell lines using demethylating agents and histone deacetylase inhibitors
- (2010) Elliot J. Mitmaker et al. SURGERY
- Estimating Risk of Recurrence in Differentiated Thyroid Cancer After Total Thyroidectomy and Radioactive Iodine Remnant Ablation: Using Response to Therapy Variables to Modify the Initial Risk Estimates Predicted by the New American Thyroid Association Staging System
- (2010) R. Michael Tuttle et al. THYROID
- Cancer Statistics, 2009
- (2009) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Increased Phosphorylation-Dependent Nuclear Export of Class II Histone Deacetylases in Failing Human Heart
- (2009) Mihail B. Calalb et al. CTS-Clinical and Translational Science
- Histone Deacetylase Inhibitors
- (2009) Xujun Ma et al. DRUGS
- Diagnostic markers and prognostic factors in thyroid cancer
- (2009) Menno R Vriens et al. Future Oncology
- Histone deacetylase 1, 2, 6 and acetylated histone H4 in B- and T-cell lymphomas
- (2009) Lena Marquard et al. HISTOPATHOLOGY
- Histone Deacetylase Inhibitors in Cancer Therapy
- (2009) Andrew A. Lane et al. JOURNAL OF CLINICAL ONCOLOGY
- Class I histone deacetylases 1, 2 and 3 are highly expressed in renal cell cancer
- (2008) Florian R Fritzsche et al. BMC CANCER
- HDAC expression and clinical prognosis in human malignancies
- (2008) Wilko Weichert CANCER LETTERS
- Class I Histone Deacetylase Expression Has Independent Prognostic Impact in Human Colorectal Cancer: Specific Role of Class I Histone Deacetylases In vitro and In vivo
- (2008) W. Weichert et al. CLINICAL CANCER RESEARCH
- Histone Deacetylase 8 in Neuroblastoma Tumorigenesis
- (2008) I. Oehme et al. CLINICAL CANCER RESEARCH
- Recent developments in predicting thyroid malignancy
- (2008) Michael T Stang et al. CURRENT OPINION IN ONCOLOGY
- Epigenetic Dysregulation in Thyroid Neoplasia
- (2008) Tetsuo Kondo et al. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA
- Prognostic significance of the therapeutic targets histone deacetylase 1, 2, 6 and acetylated histone H4 in cutaneous T-cell lymphoma
- (2008) L Marquard et al. HISTOPATHOLOGY
- Association of patterns of class I histone deacetylase expression with patient prognosis in gastric cancer: a retrospective analysis
- (2008) Wilko Weichert et al. LANCET ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started